These 4 Measures Indicate That Nomura Research Institute (TSE:4307) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know worries about.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. We can see that Nomura Research Institute, Ltd. (TSE:4307) does use debt in its business. But should shareholders be worried about its use of debt?
Why Does Debt Bring Risk?
Debt assists a business until the business has trouble paying it off, either with new capital or with free cash flow. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. Of course, plenty of companies use debt to fund growth, without any negative consequences. The first step when considering a company's debt levels is to consider its cash and debt together.
See our latest analysis for Nomura Research Institute
What Is Nomura Research Institute's Debt?
The image below, which you can click on for greater detail, shows that at September 2024 Nomura Research Institute had debt of JP¥250.1b, up from JP¥232.6b in one year. On the flip side, it has JP¥147.3b in cash leading to net debt of about JP¥102.8b.
How Strong Is Nomura Research Institute's Balance Sheet?
We can see from the most recent balance sheet that Nomura Research Institute had liabilities of JP¥199.8b falling due within a year, and liabilities of JP¥283.4b due beyond that. Offsetting this, it had JP¥147.3b in cash and JP¥121.6b in receivables that were due within 12 months. So its liabilities total JP¥214.4b more than the combination of its cash and short-term receivables.
Since publicly traded Nomura Research Institute shares are worth a very impressive total of JP¥2.67t, it seems unlikely that this level of liabilities would be a major threat. Having said that, it's clear that we should continue to monitor its balance sheet, lest it change for the worse.
We measure a company's debt load relative to its earnings power by looking at its net debt divided by its earnings before interest, tax, depreciation, and amortization (EBITDA) and by calculating how easily its earnings before interest and tax (EBIT) cover its interest expense (interest cover). The advantage of this approach is that we take into account both the absolute quantum of debt (with net debt to EBITDA) and the actual interest expenses associated with that debt (with its interest cover ratio).
Nomura Research Institute has a low net debt to EBITDA ratio of only 0.59. And its EBIT covers its interest expense a whopping 80.4 times over. So you could argue it is no more threatened by its debt than an elephant is by a mouse. And we also note warmly that Nomura Research Institute grew its EBIT by 11% last year, making its debt load easier to handle. There's no doubt that we learn most about debt from the balance sheet. But it is future earnings, more than anything, that will determine Nomura Research Institute's ability to maintain a healthy balance sheet going forward. So if you want to see what the professionals think, you might find this free report on analyst profit forecasts to be interesting.
Finally, a company can only pay off debt with cold hard cash, not accounting profits. So we clearly need to look at whether that EBIT is leading to corresponding free cash flow. During the last three years, Nomura Research Institute produced sturdy free cash flow equating to 63% of its EBIT, about what we'd expect. This free cash flow puts the company in a good position to pay down debt, when appropriate.
Our View
Happily, Nomura Research Institute's impressive interest cover implies it has the upper hand on its debt. And that's just the beginning of the good news since its net debt to EBITDA is also very heartening. Zooming out, Nomura Research Institute seems to use debt quite reasonably; and that gets the nod from us. After all, sensible leverage can boost returns on equity. Above most other metrics, we think its important to track how fast earnings per share is growing, if at all. If you've also come to that realization, you're in luck, because today you can view this interactive graph of Nomura Research Institute's earnings per share history for free.
At the end of the day, it's often better to focus on companies that are free from net debt. You can access our special list of such companies (all with a track record of profit growth). It's free.
Valuation is complex, but we're here to simplify it.
Discover if Nomura Research Institute might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:4307
Nomura Research Institute
Provides consulting, financial information technology (IT) solution, industrial IT solution, and IT platform services in Japan and internationally.
Outstanding track record with excellent balance sheet and pays a dividend.